U.S. District Judge Richard Leon said that the FDA violated its policies by allowing sodium thiopental into the country without first ensuring its safety and effectiveness. Mr. Leon called the anesthetic a misbranded and unapproved drug, ordering Arizona, California, Georgia, South Carolina and Tennessee and any other states in possession of the drug to return it to the FDA.
“Prisoners on death row have an unnecessary risk that they will not be anesthetized properly prior to execution,” Mr. Leon wrote.
Related Articles on Anesthesia:
Study: Dexamethasone Effectively Reduces Postoperative Nausea
I-Flow Launches Peripheral Nerve Block Kits
3 Reasons Why Anesthesia Providers Should Lead the OR
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
